5-Substituted-2-thiohydantoin analogs as a novel class of antitumor agents

Anti-Cancer Drugs

Volumn 7, Issue 8, 1996, Pages 873-880

  Al Obaid, A M ^a   El Subbagh, H I ^a   Khodair, Al ^b   Elmazar, M M A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Kafr Elsheikh Branch   (Egypt)

Author keywords

2 thiohydantoins; antitumor screening; nucleotides

Indexed keywords

5 (5 BROMO 2 THIENYLMETHYLENE) 2 THIOHYDANTOIN; ANTINEOPLASTIC AGENT; THIOHYDANTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

EID: 4444363138     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199611000-00009     Document Type: Article

References (15)

1. Archer S, Rabindra R. Nitro and amino derivatives of Lucanthone as antitumor agents. J Med Chem 1982; 25: 328-31.
2. Archer S, Zayed A, Rabindra R, Rugino T. Analogues of Hycanthone and Lucanthone as antitumor agents. J Med Chem 1983; 26: 1240-6.
3. Rewcastle GW, Atwell GJ. Plamer BD, Boyed PD, Boguley BC, Denny WA. Potential antitumor agents, SAR for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acid. J Med Chem 1991; 34: 491-6.
4. Abel G, Connors TA, Ross WCJ, Hoellinger H, Pichat L. The selective concentration of Sulphadiazine and related compounds in malignant tissue. Eur J Cancer 1973; 9: 49-54.
5. Branda RF, McCormack JJ, Perlmuner CA. Pharmacology of Chloroquinoxaline sulfonamide and related compound in murine B16 melanoma. Biochem Pharmacol 1988; 37: 4557-64.
6. Brada RF, Moore AL, McCormack JJ. Immunosuppressive properties of Chloroquinoxaline sulfonamide. Biochem Pharmacol 1989; 88: 3521-6.
7. Yoshino H, Ueda N, Niijima J, Sugumi H, et al. Novel sulfonamides as potential, systemically active antitumor agents. J Med Chem 1992; 35: 2496-7.
8. El-Subbagh HI, El-Sherbeny MA, Nasr MN, Goda FE, Badria FA. Novel diarylsulphide derivatives as potential cytotoxic agents. Boll Chim Farmaceutico 1995; 134: 80-4.
9. El-Sherbeny MA, El-Ashmawy MB, El-Subbagh HI, et al. Synthesis, antimicrobial and antiviral evaluation of certain thienopyrimidine derivatives. Eur J Med Chem 1995; 30: 445-9.
10. Shehata IA, El-Subbagh HI, Abdelal AM, et al. Synthesis, antitumor and anti-HIV-1 testing of certain thieno-[2,3-d]pyrimidine, thieno[2,3-d]imidazo[1,2-c] pyrimidine and thieno[2,3-d][1,3]thiazine derivatives. Med Chem Res 1996; 7: 148-63.
11. El-Subbagh HI, El-Naggar WA, Badria FA. Synthesis and biological testing of 2,4-disubstituted thiazole derivatives as potential antitumor antibioties. Med Chem Res 1994; 3: 503-16.
12. Khodair AI, El-Subbagh HI, El-Emam AA. Synthesis of 2-thiohydantoin analogues with various substituents at position 5- as antiviral agents. Monatsh Chem 1996; in press.
13. Grever MR, Schepartz SA, Chabner BA. The national cancer institute cancer drug discovery and development program. Semin Oncol 1992; 19: 622 38.
14. Monks A, Scudiero D, Skehan P, et al. Feasibility of a high-flux anticancer drug screen utilizing a drive panel of human tumor cell lines in culture. J Natl Cancer Inst 1991; 83: 757-66.
15. Boyd MR, Paull KD. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev Res 1995; 34: 91-109.